{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:18:38Z","timestamp":1792315118634,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T00:00:00Z","timestamp":1399939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-332","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T09:10:04Z","timestamp":1399972204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology"],"prefix":"10.1186","volume":"14","author":[{"given":"Sylvia","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Eray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Brunnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Kujala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Vornanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"key":"4522_CR1","volume-title":"International Agency for Research on Cancer. World Health Organization: WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH: International Agency for Research on Cancer. World Health Organization: WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. 2008, Lyon, France: International Agency for Research on Cancer"},{"issue":"7 Suppl","key":"4522_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/annonc\/7.suppl_4.S61","volume":"4","author":"M Sextro","year":"1996","unstructured":"Sextro M, Diehl V, Franklin J, Hansmann ML, Anagnostopoulos I, Marafioti T, Stein H: Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma. Ann Oncol. 1996, 4 (7 Suppl): 61-65.","journal-title":"Ann Oncol"},{"issue":"5","key":"4522_CR3","first-page":"1889","volume":"96","author":"I Anagnostopoulos","year":"2000","unstructured":"Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, Van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H: European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 2000, 96 (5): 1889-1899.","journal-title":"Blood"},{"issue":"10","key":"4522_CR4","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA: Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003, 27 (10): 1346-1356. 10.1097\/00000478-200310000-00007.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"4522_CR5","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","volume":"102","author":"L Boudova","year":"2003","unstructured":"Boudova L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Muller-Hermelink HK, Rudiger T: Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma. Blood. 2003, 102 (10): 3753-3758. 10.1182\/blood-2003-02-0626.","journal-title":"Blood"},{"issue":"10","key":"4522_CR6","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"V Brune","year":"2008","unstructured":"Brune V, Tiacci E, Pfeil I, Doring C, Eckerle S, Van Noesel CJ, Klapper W, Falini B, Von Heydebreck A, Metzler D, Brauninger A, Hansmann ML, Kuppers R: Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008, 205 (10): 2251-2268. 10.1084\/jem.20080809.","journal-title":"J Exp Med"},{"issue":"11","key":"4522_CR7","doi-asserted-by":"publisher","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","volume":"8","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, Doring C, Jakobus C, Rengstl B, Newrzela S, Tousseyn T, Sagaert X, Ponzoni M, Facchetti F, De Wolf-Peeters C, Steidl C, Gascoyne R, Kuppers R, Hansmann ML: Nodular lymphocyte predominant hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma - endpoints of a spectrum of one disease?. PLoS One. 2013, 8 (11): e78812-10.1371\/journal.pone.0078812.","journal-title":"PLoS One"},{"issue":"4","key":"4522_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/path.2242","volume":"213","author":"S Tedoldi","year":"2007","unstructured":"Tedoldi S, Mottok A, Ying J, Paterson JC, Cui Y, Facchetti F, Van Krieken JH, Ponzoni M, Ozkal S, Masir N, Natkunam Y, Pileri S, Hansmann ML, Mason D, Tao Q, Marafioti T: Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. J Pathol. 2007, 213 (4): 429-440. 10.1002\/path.2242.","journal-title":"J Pathol"},{"issue":"9","key":"4522_CR9","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","volume":"110","author":"A Mottok","year":"2007","unstructured":"Mottok A, Renne C, Willenbrock K, Hansmann ML, Brauninger A: Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood. 2007, 110 (9): 3387-3390. 10.1182\/blood-2007-03-082511.","journal-title":"Blood"},{"issue":"3","key":"4522_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1182\/blood-2011-03-341560","volume":"118","author":"S Saarinen","year":"2011","unstructured":"Saarinen S, Aavikko M, Aittomaki K, Launonen V, Lehtonen R, Franssila K, Lehtonen HJ, Kaasinen E, Broderick P, Tarkkanen J, Bain BJ, Bauduer F, Unal A, Swerdlow AJ, Cooke R, Makinen MJ, Houlston R, Vahteristo P, Aaltonen LA: Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood. 2011, 118 (3): 493-498. 10.1182\/blood-2011-03-341560.","journal-title":"Blood"},{"issue":"7","key":"4522_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.2012.43.5958","volume":"31","author":"S Saarinen","year":"2013","unstructured":"Saarinen S, Pukkala E, Vahteristo P, Makinen MJ, Franssila K, Aaltonen LA: High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol. 2013, 31 (7): 938-943. 10.1200\/JCO.2012.43.5958.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4522_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ajh.23482","volume":"88","author":"M Merli","year":"2013","unstructured":"Merli M, Maffioli M, Ferrario A, Passamonti F: Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma. Am J Hematol. 2013, 88 (8): 719-720.","journal-title":"Am J Hematol"},{"issue":"8","key":"4522_CR13","first-page":"599","volume":"12","author":"JT Sundeen","year":"1988","unstructured":"Sundeen JT, Cossman J, Jaffe ES: Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent \"large cell lymphoma\". Histological progression or composite malignancy?. Am J Surg Pathol. 1988, 12 (8): 599-606.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"4522_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0046-8177(89)80007-3","volume":"20","author":"ML Hansmann","year":"1989","unstructured":"Hansmann ML, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K: Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol. 1989, 20 (12): 1169-1175. 10.1016\/S0046-8177(89)80007-3.","journal-title":"Hum Pathol"},{"issue":"8","key":"4522_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1080\/1042819031000149421","volume":"45","author":"JZ Huang","year":"2004","unstructured":"Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO: Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma. 2004, 45 (8): 1551-1557. 10.1080\/1042819031000149421.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"4522_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","volume":"28","author":"M Al-Mansour","year":"2010","unstructured":"Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ: Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol. 2010, 28 (5): 793-799. 10.1200\/JCO.2009.24.9516.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4522_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, Coiffier B, Bosly A, Divine M, Brice P: Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer. 2010, 116 (3): 631-639. 10.1002\/cncr.24819.","journal-title":"Cancer"},{"issue":"10","key":"4522_CR18","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/annonc\/mdq063","volume":"21","author":"C Jackson","year":"2010","unstructured":"Jackson C, Sirohi B, Cunningham D, Horwich A, Thomas K, Wotherspoon A: Lymphocyte-predominant Hodgkin lymphoma\u2013clinical features and treatment outcomes from a 30-year experience. Ann Oncol. 2010, 21 (10): 2061-2068. 10.1093\/annonc\/mdq063.","journal-title":"Ann Oncol"},{"issue":"6","key":"4522_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1365-2559.2011.04054.x","volume":"59","author":"CV Cotta","year":"2011","unstructured":"Cotta CV, Coleman JF, Li S, Hsi ED: Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Histopathology. 2011, 59 (6): 1194-1203. 10.1111\/j.1365-2559.2011.04054.x.","journal-title":"Histopathology"},{"issue":"10","key":"4522_CR20","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1182\/blood-2004-10-4008","volume":"105","author":"C Renn\u00e9","year":"2005","unstructured":"Renn\u00e9 C, Willenbrock K, K\u00fcppers R, Hansmann ML, Br\u00e4uninger A: Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood. 2005, 105 (10): 4051-4059. 10.1182\/blood-2004-10-4008.","journal-title":"Blood"},{"issue":"5","key":"4522_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.immuni.2013.04.009","volume":"38","author":"K Ochiai","year":"2013","unstructured":"Ochiai K, Maienschein-Cline M, Simonetti G, Chen J, Rosenthal R, Brink R, Chong AS, Klein U, Dinner AR, Singh H, Sciammas R: Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of IRF4. Immunity. 2013, 38 (5): 918-929. 10.1016\/j.immuni.2013.04.009.","journal-title":"Immunity"},{"issue":"26","key":"4522_CR22","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","volume":"122","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, Eichenauer DA, Plutschow A, Mottok A, Bob R, Koch K, Bernd HW, Cogliatti S, Hummel M, Feller AC, Ott G, Moller P, Rosenwald A, Stein H, Hansmann ML, Engert A, Klapper W: The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 2013, 122 (26): 4246-4252. 10.1182\/blood-2013-07-515825.","journal-title":"Blood"},{"key":"4522_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","volume":"90","author":"KP Lam","year":"1997","unstructured":"Lam KP, K\u00fchn R, Rajewsky K: In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 1997, 90: 1073-1083. 10.1016\/S0092-8674(00)80373-6.","journal-title":"Cell"},{"key":"4522_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","volume":"117","author":"M Kraus","year":"2004","unstructured":"Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K: Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer. Cell. 2004, 117: 787-800. 10.1016\/j.cell.2004.05.014.","journal-title":"Cell"},{"issue":"3","key":"4522_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrd3937","volume":"12","author":"RM Young","year":"2013","unstructured":"Young RM, Staudt LM: Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov. 2013, 12 (3): 229-243. 10.1038\/nrd3937.","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"4522_CR26","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1073\/pnas.89.16.7295","volume":"89","author":"ES Alnemri","year":"1992","unstructured":"Alnemri ES, Robertson NM, Fernandes TF, Croce CM, Litwack G: Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc Natl Acad Sci U S A. 1992, 89 (16): 7295-7299. 10.1073\/pnas.89.16.7295.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"4522_CR27","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1073\/pnas.88.16.6961","volume":"88","author":"DM Hockenbery","year":"1991","unstructured":"Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991, 88 (16): 6961-6965. 10.1073\/pnas.88.16.6961.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4522_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18632\/oncotarget.774","volume":"4","author":"B Schif","year":"2013","unstructured":"Schif B, Lennerz JK, Kohler CW, Bentink S, Kreuz M, Melzner I, Ritz O, Trumper L, Loeffler M, Spang R, Moller P: SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients. Oncotarget. 2013, 4 (1): 35-47.","journal-title":"Oncotarget"},{"issue":"5","key":"4522_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2559.2011.03829.x","volume":"58","author":"G Venkataraman","year":"2011","unstructured":"Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES: CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology. 2011, 58 (5): 803-805. 10.1111\/j.1365-2559.2011.03829.x.","journal-title":"Histopathology"},{"issue":"3","key":"4522_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","volume":"38","author":"AR Huppmann","year":"2014","unstructured":"Huppmann AR, Nicolae A, Slack GW, Pittaluga S, Davies-Hill T, Ferry JA, Harris NL, Jaffe ES, Hasserjian RP: EBV May Be Expressed in the LP Cells of Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults. Am J Surg Pathol. 2014, 38 (3): 316-324. 10.1097\/PAS.0000000000000107.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4522_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ajcp\/102.3.292","volume":"102","author":"GH Segal","year":"1994","unstructured":"Segal GH, Kjeldsberg CR, Smith GP, Perkins SL: CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases. Am J Clin Pathol. 1994, 102 (3): 292-298.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"4522_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/TP.0b013e318274ab63","volume":"95","author":"EA Engels","year":"2013","unstructured":"Engels EA, Savoldo B, Pfeiffer RM, Costello R, Zingone A, Heslop HE, Landgren O: Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients. Transplantation. 2013, 95 (3): 519-526. 10.1097\/TP.0b013e318274ab63.","journal-title":"Transplantation"},{"issue":"10","key":"4522_CR33","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1128\/IAI.00887-13","volume":"81","author":"Y Guo","year":"2013","unstructured":"Guo Y, Sun X, Shibata K, Yamada H, Muta H, Podack ER, Yoshikai Y: CD30 is required for activation of a unique subset of interleukin-17A-producing gammadelta T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection. Infect Immun. 2013, 81 (10): 3923-3934. 10.1128\/IAI.00887-13.","journal-title":"Infect Immun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-332\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T07:49:57Z","timestamp":1565423397000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4522"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-332","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,13]]},"article-number":"332"}}